This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
Information provided by:
Tel-Aviv Sourasky Medical Center Identifier:
First received: June 11, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
Brain metastases (BM) are the most common intracranial tumors in adults and source of the most common neurological complications of systemic cancer. Surgery and radiation therapy are the most important components in the management of BM with the goal to prolong survival and improve the quality of life. Whole brain radiotherapy (WBRT) has shown to increase local and distant control both with and without surgical resection. However, patients who develop a new or recurrent BM after WBRT and undergo resection are left without adjuvant therapy options. Local recurrence particular in patients with single metastasis does effect both survival and quality of life. In individual cases the option of additional radiotherapy has been suggested and applied. We seek to evaluate the addition of a stereotactic radiosurgery (SRS) boost to the resection cavity both as adjuvant and salvage procedure among patients, who undergo resection of a BM and previously received WBRT or decline WBRT. Goal is to show superior local brain control.

Condition Intervention Phase
Brain Neoplasms Procedure: Stereotactic Radiosurgery Phase 2

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Single Center Prospective Phase II Study: Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Primary Outcome Measures:
  • Improved local tumor control after resection [ Time Frame: 6months and 12 months ]

Secondary Outcome Measures:
  • Overall survival Quality of life [ Time Frame: QoL 3-6-12months and overall survival ]

Estimated Enrollment: 35
Study Start Date: February 2007
Estimated Study Completion Date: June 2007
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient must have undergone surgical resection of a brain metastasis
  • Patients with no more than 3 brain metastases on contrast MRI.
  • Previous WBRT for brain malignancy, except patients with melanoma, renal cell carcinoma.
  • Adult patient aged > 18.
  • Patient must be in adequate general health, as indicated by:

    • Karnofsky performance status equal or greater than 60.
    • The absence of a concomitant life-threatening disease other than the malignancy.
  • Patient must understand the investigational nature of this study and sign informed consent form, approved by the Institutional Review Board.

Exclusion Criteria:

  • Pregnancy
  • Patients unable or unwilling to follow protocol requirements
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00484978

Contact: Andrew A. Kanner, MD 972-3-6974273
Contact: Lina Vizelman 972-3-6974098

Tel Aviv Sourasky Medical Center Recruiting
Tel Aviv, Israel
Contact: Andrew A Kanner, MD    972-3-6974273   
Contact: Lina Vizelman    972-3-6974098   
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Principal Investigator: Andrew A Kanner, MD Tel Aviv Medical Center, affiliated Tel Aviv University
  More Information Identifier: NCT00484978     History of Changes
Other Study ID Numbers: 07-056 TASMC
Study First Received: June 11, 2007
Last Updated: June 11, 2007

Keywords provided by Tel-Aviv Sourasky Medical Center:
Stereotactic Radiosurgery
Metastatic tumor to brain
Brain Metastases of all pathologies

Additional relevant MeSH terms:
Neoplasm Metastasis
Brain Neoplasms
Neoplastic Processes
Pathologic Processes
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases processed this record on September 25, 2017